A detailed history of Quest Partners LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 49,300 shares of CTLT stock, worth $2.95 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
49,300
Previous 12,648 289.78%
Holding current value
$2.95 Million
Previous $711 Million 319.87%
% of portfolio
0.27%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$56.16 - $60.96 $2.06 Million - $2.23 Million
36,652 Added 289.78%
49,300 $2.99 Billion
Q2 2024

Aug 06, 2024

BUY
$53.58 - $57.02 $677,144 - $720,618
12,638 Added 126380.0%
12,648 $711 Million
Q1 2024

May 09, 2024

BUY
$42.56 - $59.82 $425 - $598
10 New
10 $565,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.